X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13816) 13816
Book Review (3033) 3033
Publication (1464) 1464
Newsletter (240) 240
Book Chapter (100) 100
Conference Proceeding (67) 67
Newspaper Article (28) 28
Magazine Article (22) 22
Dissertation (9) 9
Data Set (4) 4
Book / eBook (3) 3
Reference (3) 3
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11665) 11665
animals (7768) 7768
humans (7713) 7713
alzheimer's disease (5786) 5786
neurosciences (4164) 4164
alzheimers-disease (4088) 4088
mice (3428) 3428
male (2532) 2532
biochemistry & molecular biology (2525) 2525
rats (2477) 2477
amyloid beta-peptides - metabolism (2331) 2331
alzheimer disease - metabolism (2121) 2121
alzheimer disease - drug therapy (2084) 2084
amyloid precursor protein (2057) 2057
amyloid precursor protein secretases - antagonists & inhibitors (1743) 1743
pharmacology & pharmacy (1682) 1682
brain (1680) 1680
amyloid beta-peptides - antagonists & inhibitors (1657) 1657
amyloid beta-protein (1653) 1653
female (1559) 1559
cells, cultured (1543) 1543
disease models, animal (1320) 1320
cell biology (1290) 1290
proteins (1275) 1275
oxidative stress (1237) 1237
neurology (1210) 1210
alzheimer disease - pathology (1202) 1202
mice, transgenic (1186) 1186
alzheimer’s disease (1183) 1183
neurons - drug effects (1169) 1169
neurons - metabolism (1097) 1097
amyloid precursor protein secretases - metabolism (1095) 1095
analysis (1078) 1078
amyloid-beta (1072) 1072
a-beta (1042) 1042
alzheimers disease (1037) 1037
neurons (1037) 1037
amyloid (1021) 1021
article (1010) 1010
neurodegenerative diseases (1004) 1004
inflammation (988) 988
dose-response relationship, drug (972) 972
transgenic mice (969) 969
chemistry, medicinal (968) 968
research (963) 963
brain - metabolism (956) 956
amyloid beta-protein precursor - metabolism (949) 949
apoptosis (935) 935
enzyme inhibitors - pharmacology (926) 926
amyloid beta-peptides - toxicity (907) 907
mice, inbred c57bl (890) 890
in-vivo (889) 889
mouse model (872) 872
neuroprotective agents - pharmacology (854) 854
expression (852) 852
peptides (851) 851
neurodegeneration (848) 848
protein (833) 833
peptide fragments - metabolism (819) 819
in-vitro (804) 804
cell line, tumor (803) 803
rats, sprague-dawley (803) 803
alzheimer disease - physiopathology (788) 788
β-amyloid (776) 776
activation (765) 765
cell line (757) 757
physiological aspects (726) 726
dementia (715) 715
signal transduction (708) 708
memory (706) 706
peptide fragments - antagonists & inhibitors (704) 704
structure-activity relationship (703) 703
rodents (700) 700
phosphorylation (696) 696
clinical neurology (695) 695
long-term potentiation (692) 692
alzheimer disease - genetics (676) 676
amyloid beta-protein precursor - genetics (666) 666
neuroprotection (660) 660
central-nervous-system (654) 654
aged (647) 647
cell survival - drug effects (637) 637
pathology (621) 621
peptide (620) 620
neurotoxicity (617) 617
precursor protein (611) 611
drug design (608) 608
signal transduction - drug effects (605) 605
disease (602) 602
amyloid beta-peptides - pharmacology (601) 601
aspartic acid endopeptidases - antagonists & inhibitors (598) 598
cells (593) 593
hippocampus (588) 588
peptide fragments - pharmacology (580) 580
brain - drug effects (569) 569
multidisciplinary sciences (569) 569
peptide fragments - toxicity (564) 564
protein binding (562) 562
hippocampus - drug effects (561) 561
beta-amyloid (555) 555
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13994) 13994
Chinese (56) 56
Japanese (46) 46
German (25) 25
Russian (18) 18
French (15) 15
Spanish (4) 4
Hungarian (2) 2
Italian (2) 2
Portuguese (2) 2
Danish (1) 1
Greek (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuropharmacology, ISSN 0028-3908, 09/2012, Volume 63, Issue 4, pp. 653 - 666
Cannabinoids have been shown to exert neuroprotective effects in a plethora of neurodegenerative conditions. Over the past decade, some studies demonstrate... 
Neuroinflammation | CB2 | CB1 | WIN55212-2 | PPAR-γ | Beta-amyloid | NITRIC-OXIDE SYNTHASE | ALZHEIMERS-DISEASE | NEUROSCIENCES | PPAR-gamma | CELL-DEATH | CASPASE-3 ACTIVATION | CORTICAL-NEURONS | SIGNALING PATHWAY | DNA FRAGMENTATION | IN-VIVO | PHARMACOLOGY & PHARMACY | INFLAMMATORY RESPONSE | NF-KAPPA-B | Receptor, Cannabinoid, CB2 - agonists | Neuroglia - pathology | Injections, Intraventricular | Male | PPAR gamma - metabolism | Alzheimer Disease - pathology | Cannabinoid Receptor Agonists - therapeutic use | Neuroglia - immunology | Nootropic Agents - antagonists & inhibitors | Cannabinoid Receptor Antagonists - pharmacology | Neurons - metabolism | Alzheimer Disease - immunology | Morpholines - therapeutic use | Receptors, Cannabinoid - chemistry | Disease Models, Animal | Benzoxazines - administration & dosage | Nerve Tissue Proteins - agonists | Alzheimer Disease - drug therapy | Rats | Hippocampus - pathology | Random Allocation | PPAR gamma - antagonists & inhibitors | Signal Transduction - drug effects | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Naphthalenes - therapeutic use | Neurons - pathology | Rats, Wistar | Hippocampus - drug effects | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Cannabinoid Receptor Agonists - chemistry | Neuroglia - drug effects | Receptors, Cannabinoid - metabolism | Anti-Inflammatory Agents, Non-Steroidal - antagonists & inhibitors | Receptor, Cannabinoid, CB1 - agonists | Morpholines - antagonists & inhibitors | Benzoxazines - antagonists & inhibitors | Neurons - drug effects | Nerve Tissue Proteins - antagonists & inhibitors | Hippocampus - immunology | Morpholines - administration & dosage | Neurons - immunology | Nootropic Agents - therapeutic use | Cannabinoid Receptor Agonists - administration & dosage | Benzoxazines - therapeutic use | Nerve Tissue Proteins - metabolism | Hippocampus - metabolism | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Nootropic Agents - administration & dosage | Naphthalenes - administration & dosage | Alzheimer Disease - metabolism | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | PPAR gamma - agonists | Neuroglia - metabolism | Naphthalenes - antagonists & inhibitors | Index Medicus
Journal Article
Trends in Molecular Medicine, ISSN 1471-4914, 02/2019, Volume 25, Issue 2, pp. 74 - 76
Recent studies revealed that cellular prion protein on neurons bind Alzheimer's amyloid-β oligomers, causing neurotoxic effects. A new article in Cell Reports... 
amyloid-β oligomers | cellular prion protein | cognition | Alzheimer's disease | antagonist | MEDICINE, RESEARCH & EXPERIMENTAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | IMPAIRMENT | CELL BIOLOGY
Journal Article
Psychopharmacology, ISSN 0033-3158, 12/2014, Volume 231, Issue 24, pp. 4711 - 4722
Journal Article
Journal of Immunology, ISSN 0022-1767, 12/2011, Volume 187, Issue 12, pp. 6539 - 6549
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2009, Volume 106, Issue 48, pp. 20504 - 20509
Journal Article
Trends in Molecular Medicine, ISSN 1471-4914, 02/2019, Volume 25, Issue 2, pp. 74 - 76
Recent studies revealed that cellular prion protein on neurons bind Alzheimer’s amyloid-β oligomers, causing neurotoxic effects. A new article in by Gunther... 
cellular prion protein | Alzheimer’s disease | amyloid-β oligomers | cognition | antagonist
Journal Article
Experimental Neurology, ISSN 0014-4886, 01/2007, Volume 203, Issue 1, pp. 241 - 245
Consumption of caffeine, an adenosine receptor antagonist, was found to be inversely associated with the incidence of Alzheimer's disease. Moreover, caffeine... 
Neuroprotection | Adenosine | receptor | Memory | Alzheimer's disease | β-amyloid | Caffeine
Journal Article
MEDICINAL RESEARCH REVIEWS, ISSN 0198-6325, 07/2015, Volume 35, Issue 4, pp. 790 - 848
Journal Article
EXPERIMENTAL NEUROLOGY, ISSN 0014-4886, 01/2007, Volume 203, Issue 1, pp. 241 - 245
Consumption of caffeine, an adenosine receptor antagonist, was found to be inversely associated with the incidence of Alzheimer's disease. Moreover, caffeine... 
memory | A(2A) receptor | ALZHEIMERS-DISEASE | INVOLVEMENT | RELEASE | NEUROTOXICITY | NEUROSCIENCES | NUCLEUS-ACCUMBENS | adenosine | beta-amyloid | HIPPOCAMPUS | caffeine | neuroprotection | GLUTAMATE | Alzheimer's disease | Neuroprotective Agents - therapeutic use | Phosphodiesterase Inhibitors - therapeutic use | Cognition Disorders - chemically induced | Male | Adenosine A2 Receptor Antagonists | Brain - metabolism | Amnesia - chemically induced | Amnesia - drug therapy | Neuroprotective Agents - pharmacology | Caffeine - therapeutic use | Caffeine - pharmacology | Disease Models, Animal | Triazoles - therapeutic use | Alzheimer Disease - physiopathology | Cognition Disorders - physiopathology | Maze Learning - physiology | Brain - physiopathology | Alzheimer Disease - drug therapy | Phosphodiesterase Inhibitors - pharmacology | Treatment Outcome | Avoidance Learning - physiology | Pyrimidines - pharmacology | Receptor, Adenosine A2A - metabolism | Cognition Disorders - drug therapy | Maze Learning - drug effects | Amyloid beta-Peptides - adverse effects | Brain - drug effects | Drug Synergism | Triazoles - pharmacology | Amyloid beta-Peptides - antagonists & inhibitors | Amnesia - physiopathology | Animals | Peptide Fragments - antagonists & inhibitors | Pyrimidines - therapeutic use | Alzheimer Disease - metabolism | Avoidance Learning - drug effects | Mice | Peptide Fragments - adverse effects | Index Medicus
Journal Article
Psychoneuroendocrinology, ISSN 0306-4530, 04/2018, Volume 90, pp. 92 - 101
Journal Article
Journal Article